The Solana Foundation has introduced Frontier Traders, a rewards program that tracks trading activity across 16 venues and offers VIP benefits to high-volume professional traders, including market makers and hedge funds. The program features tiered rebates based on trading volume, starting at $10 million monthly, and provides perks like priority network access and dedicated account management. With over 2,000 traders enrolled and Flint Trade joining as a venue, Frontier aims to attract more liquidity to Solana's ecosystem by incentivizing cross-platform trading and supporting smaller decentralized exchanges. This initiative enhances network connectivity and acts as a shared marketing tool for the founding venues, subsidized by the Solana Foundation.
The story about Solana's new Frontier rewards program for professional traders is presented alongside a snapshot of the broader cryptocurrency market on Pluang as of Sep 15, 2026 20:32 WIB. Among 50 major cryptocurrencies, 18 rose and 31 fell today. Notably, XLM (Stellar) gained 3.53% to Rp3.487 with a typical hold time of 83 days and a Pluang order activity skewed 59% Buy, contrasting with CRV (Curve DAO Token) which dropped 3.31% to Rp5.934 and showed a stronger buy interest at 81%, while COTI rose 3.06% to Rp303 but had a majority sell order activity at 76%.
The global clinical trial supplies market is projected to grow from $5.7 billion in 2025 to $10.7 billion by 2033, at an 8.4% CAGR. This growth is driven by increased R&D investments, rising chronic diseases, and the expansion of biologics, personali...
Starlink Mobile, launched by VEON Ltd. across Ukraine, Kazakhstan, and Bangladesh, has connected over 11 million users in less than a year. The service enables existing 4G phones to access satellite connectivity where terrestrial signals are unavaila...
Medallion Financial Corp. announced it will repurchase $15 million in trust preferred securities from BIMIZCI Fund LLC at 73.66% of face value, costing about $11.05 million plus accrued distributions. This deal includes a five-year standstill agreeme...
Belite Bio, a clinical-stage drug developer focused on retinal diseases, has been approved to move its stock listing from the Nasdaq Capital Market to the Nasdaq Global Select Market, the highest tier on Nasdaq. This uplisting reflects the company's ...
Heineken N.V. has repurchased a total of 8,865,521 shares under the second tranche of its €1.5 billion share buyback program, spending €629.4 million as of October 16, 2026. This includes shares bought on the exchange and from Heineken Holding N.V. T...
